Clinical Medical College of Jining Medical University, Jining Medical University, Jining, China.
Jining NO.1 People's Hospital, Jining, China.
Medicine (Baltimore). 2024 Feb 23;103(8):e36509. doi: 10.1097/MD.0000000000036509.
This study aimed to investigate the molecular mechanisms underlying the aging of hematopoietic stem cells (HSCs). Gene expression profile GSE32719 was downloaded from the Gene Expression Omnibus database, including 14 young, 5 middle, and 8 old HSCs. Differential expression analysis, short time-series expression miner analysis, and weighted co-expression network analysis were conducted to screen for hub genes whose expression changed over time during HSC aging. Subsequently, functional enrichment and multiple regulatory network analyses of the hub genes were performed. A total of 124 intersecting time-dependent differentially expressed and module genes were obtained, which were considered hub genes whose expression changed over time during HSC aging. Hub genes were significantly enriched in pathways such as the Hippo and AMP-activated protein kinase (AMPK) signaling pathways. Moreover, AP-1 Transcription Factor Subunit (FOS) and sirtuin 1 (SIRT1) had higher degrees in the protein-protein interaction network, were regulated by more transcription factors (TFs), such as Sp1 transcription factor (SP1) and BRCA1 DNA repair-associated (BRCA1), in the TF-mRNA-miRNA network, were associated with more diseases in the disease-gene network, and could be targeted by more drugs in the drug-gene network. Furthermore, SIRT1 was targeted by miR-9-5p in the TF-mRNA-miRNA network. Hub genes such as FOS and SIRT1 and key pathways such as the Hippo and AMPK signaling pathways may play crucial roles in HSC aging. Moreover, FOS and SIRT1 were regulated by SP1 and BRCA1, respectively, during HSC aging. Furthermore, miR-9-5p may modulate HSC aging by targeting SIRT1. Thus, FOS and SIRT1 may be potential therapeutic targets for age-related hematopoietic dysfunction.
本研究旨在探讨造血干细胞(HSCs)衰老的分子机制。从基因表达综合数据库中下载了基因表达谱 GSE32719,其中包含 14 个年轻、5 个中年和 8 个老年 HSCs。进行差异表达分析、短时间序列表达矿化分析和加权共表达网络分析,以筛选出在 HSC 衰老过程中随时间变化的关键基因。随后,对关键基因进行功能富集和多调控网络分析。共获得 124 个重叠的时间依赖性差异表达和模块基因,这些基因被认为是在 HSC 衰老过程中随时间变化的关键基因。关键基因在 Hippo 和 AMP 激活蛋白激酶(AMPK)信号通路等途径中显著富集。此外,AP-1 转录因子亚基(FOS)和沉默调节蛋白 1(SIRT1)在蛋白质-蛋白质相互作用网络中的度数较高,在 TF-mRNA-miRNA 网络中受更多转录因子(如 Sp1 转录因子(SP1)和乳腺癌 1 修复相关(BRCA1))的调节,在疾病-基因网络中与更多疾病相关,在药物-基因网络中可被更多药物靶向。此外,在 TF-mRNA-miRNA 网络中,SIRT1 受 miR-9-5p 的靶向调控。FOS 和 SIRT1 等关键基因以及 Hippo 和 AMPK 信号通路等关键途径可能在 HSC 衰老中发挥关键作用。此外,FOS 和 SIRT1 在 HSC 衰老过程中分别受 SP1 和 BRCA1 调节。此外,miR-9-5p 可能通过靶向 SIRT1 来调节 HSC 衰老。因此,FOS 和 SIRT1 可能是与年龄相关的造血功能障碍的潜在治疗靶点。